Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Potential adverse effects and inferior efficacy in ARV treatment.

Graves D, Cocohoba J, Gruta C, Goldschmidt R.

J Natl Med Assoc. 2004 May;96(5):692-3; author reply 693. No abstract available.

2.

[Current status and future issues of anti-HIV chemotherapy].

Matsushita S.

Uirusu. 2003 Dec;53(2):141-6. Review. Japanese. No abstract available.

3.

[HIV-infection].

Wasmuth JC, Rockstroh JK.

Dtsch Med Wochenschr. 2007 Mar 30;132(13):673-83; quiz 685-6. Review. German. No abstract available.

PMID:
17377882
4.

[Adverse effects of antiviral agents].

Moriuchi M, Moriuchi H.

Nihon Rinsho. 2007 Oct 28;65 Suppl 8:233-41. Review. Japanese. No abstract available.

PMID:
18074544
5.

New antiretroviral drugs and approaches to HIV treatment.

Paredes R, Clotet B.

AIDS. 2003;17 Suppl 4:S85-96. Review. No abstract available.

PMID:
15080184
6.

Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

Pozniak AL.

HIV Med. 2000;1 Suppl 1:7-10. Review. No abstract available.

8.

HIV-associated lipodystrophy: impact of antiretroviral therapy.

Guaraldi G, Stentarelli C, Zona S, Santoro A.

Drugs. 2013 Sep;73(13):1431-50. doi: 10.1007/s40265-013-0108-1. Review.

PMID:
24002702
9.

Once-daily therapies.

Carey D.

J HIV Ther. 2003 Feb;8(1):7-11. Review.

PMID:
12840708
10.

[Antiretrovirals].

Teruya K.

Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:384-9. Review. Japanese. No abstract available.

PMID:
17455650
11.

Simplification of antiretroviral therapy with etravirine.

Martínez E, Nelson M.

AIDS Rev. 2010 Jan-Mar;12(1):52-9. Review.

PMID:
20216910
12.

Contraindicated antiretroviral drug combinations.

Macher A, Thomas D, Paul SM.

N J Med. 2003 Sep;100(9 Suppl):41-3; quiz 73-4. Review.

PMID:
14556602
13.

Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?

Maagaard A, Kvale D.

J Antimicrob Chemother. 2009 Nov;64(5):901-9. doi: 10.1093/jac/dkp316. Epub 2009 Sep 9. Review.

14.

Rhabdomyolysis in an HIV-infected patient following coronary angiography: case report and literature review.

Sbrana F, Coceani M, Iapoce R, Petersen C, Rovai D.

Int J STD AIDS. 2014 May;25(6):452-4. doi: 10.1177/0956462413512809. Epub 2013 Nov 20. Review.

PMID:
24256695
15.

Warfarin-antiretroviral interactions.

Liedtke MD, Rathbun RC.

Ann Pharmacother. 2009 Feb;43(2):322-8. doi: 10.1345/aph.1L497. Epub 2009 Feb 5. Review.

PMID:
19196837
16.

An update and review of antiretroviral therapy.

Piacenti FJ.

Pharmacotherapy. 2006 Aug;26(8):1111-33. Review.

PMID:
16863488
17.

[Antiviral therapy of HIV infection in adults].

Ormaasen V, Bruun JN.

Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3414-20. Review. Norwegian.

PMID:
11826789
18.

Initiating HIV therapy. Timing is critical, controversial.

Volberding PA.

Postgrad Med. 2004 Feb;115(2):15-8, 21, 24-6. Review.

PMID:
15000057
19.

Mitochondrial dysfunction in HIV infection: an overview of pathogenesis.

Rustin P.

J HIV Ther. 2001 Mar;6(1):4-12. Review. No abstract available.

PMID:
11501198
20.

Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer.

Sparano JA, Kalkut G.

Cancer Treat Res. 2001;104:347-66. Review. No abstract available.

PMID:
11191134
Items per page

Supplemental Content

Write to the Help Desk